Cas:28798-28-9 H-Cys(Acm)-OH HCl manufacturer & supplier

Chemical Name:H-Cys(Acm)-OH HCl

CAS.NO:28798-28-9

Synonyms:S-acetamidomethyl cysteine hydrochloride;S-acetaminomethyl-L-cysteine hydrochloride;H-Cys(Acm).HCl;S-Acetamidomethyl-L-cystein-Hydrochlorid;H-Cys(Acm)-OH HCl;H-Cys(Acm)-OH.HCl

Molecular Formula:C₆H₁₃ClN₂O₃S

Molecular Weight:228.69700

HS Code:

Physical and Chemical Properties:

Melting point:-165ºC (dec.)

Boiling point:456.5ºC at 760mmHg

Density:1.315g/cm3

Index of Refraction:

PSA:117.72000

Exact Mass:228.03400

LogP:1.11830

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like S-acetamidomethyl cysteine hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,H-Cys(Acm)-OH.HCl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,S-acetamidomethyl cysteine hydrochloride Use and application,S-acetaminomethyl-L-cysteine hydrochloride technical grade,usp/ep/jp grade.

Related News: Many domestic raw material pharmaceutical and intermediate manufacturing companies with strong capital and talent reserves and advanced technology and processes have developed in the country, and the competitiveness of market participants has continued to increase. H-Cys(Acm)-OH HCl manufacturer Later on Friday, Canada’s drug regulator said it would not release J&J’s shipment of 300,000 COVID-19 vaccine doses, which were made at the Baltimore plant. H-Cys(Acm)-OH HCl supplier Slower growth in pesticide intermediates weighed on industrial business. In the first three quarters, the company’s operating income was 2.977 billion yuan, a year-on-year increase of 2.57%. H-Cys(Acm)-OH HCl vendor Later on Friday, Canada’s drug regulator said it would not release J&J’s shipment of 300,000 COVID-19 vaccine doses, which were made at the Baltimore plant. H-Cys(Acm)-OH HCl factory From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.